Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
bioMérieux Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
bioMérieux hat ein Gesamteigenkapital von €3.8B und eine Gesamtverschuldung von €370.2M, wodurch sich der Verschuldungsgrad auf 9.9% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €5.3B bzw. €1.5B. bioMérieux Das EBIT des Unternehmens beträgt €569.0M, so dass der Zinsdeckungsgrad 172.4 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €352.4M.
Wichtige Informationen
9.9%
Verhältnis von Schulden zu Eigenkapital
€370.20m
Verschuldung
| Zinsdeckungsgrad | 172.4x |
| Bargeld | €352.40m |
| Eigenkapital | €3.75b |
| Gesamtverbindlichkeiten | €1.51b |
| Gesamtvermögen | €5.26b |
Jüngste Berichte zur Finanzlage
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Mar 15
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Oct 23Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Jun 30Is bioMérieux (EPA:BIM) Using Too Much Debt?
Mar 31bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet
Dec 16Is bioMérieux (EPA:BIM) Using Too Much Debt?
Sep 14Recent updates
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
May 30Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)
Apr 18bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings
Mar 31bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 17These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Mar 15bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
Jan 27bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward
Jan 06A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 16These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Oct 23bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger
Oct 05There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings
Sep 15Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Jun 30Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down
Jun 09Is bioMérieux (EPA:BIM) Using Too Much Debt?
Mar 31The Return Trends At bioMérieux (EPA:BIM) Look Promising
Feb 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jan 27bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet
Dec 16bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth
Oct 18Is bioMérieux (EPA:BIM) Using Too Much Debt?
Sep 14Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital
Aug 11An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued
Jul 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jul 05bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
May 26Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns
May 11bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year
Apr 23bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85
Apr 09bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
Mar 25Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Mar 13I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease
Feb 08Why We Like The Returns At bioMérieux (EPA:BIM)
Dec 21Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 07Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching
Nov 07Is bioMérieux (EPA:BIM) A Risky Investment?
Oct 07Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital
Sep 22Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Aug 06There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital
Jun 15A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)
May 31Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Apr 30bioMérieux (EPA:BIM) Could Easily Take On More Debt
Mar 28The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested
Mar 13Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Feb 25If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns
Feb 09If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late
Jan 20
Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?
Dec 30These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Dec 17Has bioMérieux (EPA:BIM) Got What It Takes To Become A Multi-Bagger?
Dec 03Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: BIMDie kurzfristigen Aktiva des Unternehmens (€2.2B) übersteigen seine kurzfristigen Passiva (€1.1B).
Langfristige Verbindlichkeiten: BIMDie kurzfristigen Vermögenswerte des Unternehmens (€2.2B) übersteigen seine langfristigen Verbindlichkeiten (€419.7M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: BIMDie Nettoverschuldung im Verhältnis zum Eigenkapital (0.5%) wird als zufriedenstellend angesehen.
Schulden abbauen: BIM Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 25.9% auf 9.9% zurückgegangen.
Schuldendeckung: BIMDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (120.3%).
Zinsdeckung: Die Zinszahlungen für die Schulden von BIM sind durch das EBIT gut gedeckt (172.4x coverage).